The study will examine how a simplified outpatient medical abortion procedure using mifepristone and misoprostol, with the option to take mifepristone at a place of woman's choosing, works in Ukraine. The investigators intend to demonstrate the efficacy of oral administration of 200 mg mifepristone and buccal administration of 800 mcg misoprostol with gestations through 70 days, as well as the acceptability of this method.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
102
Women seeking medical abortion will be offered the option to take mifepristone at home
Women seeking medical abortion will be offered the option to take misoprostol at home. Misoprostol will be administered buccally.
Lviv Municipal Women's Consultation No. 2
Lviv, Ukraine
Vinnitsa Regional Clinical Hospital
Vinnitsa, Ukraine
Rate of successful abortion
Time frame: 2 weeks after mifepristone administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.